Atlas Trials

Biomolecular Analysis for Predicting Response to Regorafenib

Clinical trial NCT05759195 · COMPLETED

Trial details

NCT number
NCT05759195
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
GlioblastomaGlioblastoma, IDH-wildtype
Start date
2021-01-07
Primary completion
2024-09-30
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.